Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2001 | 06-2001 | 03-2001 | 12-2000 | 09-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,590 | -7,130 | -7,710 | -30,230 | -22,470 |
| Depreciation Amortization | 220 | 190 | 180 | 840 | 680 |
| Other Working Capital | 450 | 6,550 | 150 | 4,200 | 2,180 |
| Other Operating Activity | 0 | 20 | 10 | 10 | 10 |
| Operating Cash Flow | $-3,920 | $-370 | $-7,370 | $-25,180 | $-19,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -200 | -130 | -20 | -820 | -560 |
| Other Investing Activity | -12,720 | 6,700 | 1,740 | -18,210 | -22,810 |
| Investing Cash Flow | $-12,920 | $6,570 | $1,720 | $-19,030 | $-23,370 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 8,820 | 16,750 | 1,620 | 46,160 | 44,380 |
| Financing Cash Flow | $8,820 | $16,750 | $1,620 | $46,160 | $44,380 |
| Beginning Cash Position | 25,090 | 2,180 | 6,210 | 4,490 | 4,490 |
| End Cash Position | 17,060 | 25,130 | 2,180 | 6,440 | 5,900 |
| Net Cash Flow | $-8,020 | $22,940 | $-4,030 | $1,950 | $1,410 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,920 | -370 | -7,370 | -25,180 | -19,600 |
| Free Cash Flow | -3,920 | -370 | -7,370 | -25,180 | -19,600 |